COM:CEREVEL
Cerevel Therapeutics
- Stock
Last Close
44.63
31/07 20:00
Market Cap
7.46B
Beta: -
Volume Today
15.03M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Aug '14 | Aug '15 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -29.32M - | -28.16M 3.97% | -128.39M 355.99% | -152.14M 18.50% | -225.33M 48.11% | -351.51M 56.00% | -432.84M 23.14% | |
depreciation and amortization | 1.52M - | 657K 56.69% | 177K 73.06% | 397K 124.29% | 2.73M 587.91% | 4.90M 79.53% | 5.63M 14.77% | |
deferred income tax | 46.44M - | 3.27M 92.96% | 3.88M 18.69% | -2.04M - | ||||
stock based compensation | 3.07M - | 2.27M 26.17% | 8.31M 266.93% | 10.52M 26.59% | 23.94M 127.55% | 38.78M 61.98% | 69.41M 78.98% | |
change in working capital | -3.83M - | -20.06M 423.56% | 343K 101.71% | 17.71M 5,062.39% | 15.54M 12.23% | 28.06M 80.58% | 16.11M 42.58% | |
accounts receivables | 589K - | -208K 135.31% | ||||||
inventory | -61K - | 65K 206.56% | ||||||
accounts payables | 390K - | 892K 128.72% | 607K 31.95% | 1.42M 133.44% | 7.28M 413.62% | -763K 110.48% | 2.04M 367.10% | |
other working capital | -4.75M - | -20.81M 338.15% | -264K 98.73% | 16.29M 6,270.45% | 8.26M 49.28% | 28.83M 248.87% | 14.08M 51.17% | |
other non cash items | 6.00M - | 22.08M 267.69% | 2.40M 89.15% | 2.44M 2.05% | 694K 71.62% | -13.42M 2,034.15% | 1.43M 110.65% | |
net cash provided by operating activities | -22.56M - | -23.22M 2.90% | -70.72M 204.60% | -117.80M 66.58% | -178.55M 51.56% | -293.19M 64.21% | -342.30M 16.75% | |
investments in property plant and equipment | -1.01M - | -387K 61.83% | -1.10M 183.98% | -18.89M 1,619.02% | -10.50M 44.41% | -3.95M 62.35% | -3.81M 3.69% | |
acquisitions net | 384.88K - | |||||||
purchases of investments | -33.09M - | -720K 97.82% | -425.16M - | -887.74M 108.80% | -865.27M 2.53% | |||
sales maturities of investments | 502.86M - | 942.80M 87.49% | ||||||
other investing activites | 30.51M - | 25.18M 17.48% | -384.88K - | |||||
net cash used for investing activites | -3.59M - | 24.07M 770.63% | -1.10M 104.57% | -18.89M 1,619.02% | -435.66M 2,206.06% | -388.83M 10.75% | 73.72M 118.96% | |
debt repayment | -159K - | -69K 56.60% | -31.25M - | -372.27M 1,091.28% | -31.25M 91.61% | |||
common stock issued | 20.75M - | 2.79M 86.54% | 60.06M 2,049.53% | 5.53M 90.79% | 328.25M 5,835.82% | 238.26M 27.41% | 517.50M 117.20% | |
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 60.06K - | 435.31M 724,707.69% | 126.60M 70.92% | 757.20M 498.10% | 62.36M 91.76% | |||
net cash used provided by financing activities | 20.59M - | 2.73M 86.77% | 60.06M 2,103.96% | 440.83M 634.02% | 423.60M 3.91% | 623.19M 47.12% | 548.62M 11.97% | |
effect of forex changes on cash | 102K - | 1.09M 973.53% | 548.75M - | |||||
net change in cash | -5.46M - | 4.67M 185.60% | -11.76M 351.73% | 304.14M 2,686.01% | -190.60M 162.67% | -58.83M 69.14% | 98.94M 268.17% | |
cash at beginning of period | 8.88M - | 3.42M 61.46% | 95.44M 2,688.29% | 83.68M 12.32% | 387.82M 363.45% | 197.22M 49.15% | 892.03M 352.31% | |
cash at end of period | 3.42M - | 8.10M 136.49% | 83.68M 933.75% | 387.82M 363.45% | 197.22M 49.15% | 138.39M 29.83% | 990.97M 616.08% | |
operating cash flow | -22.56M - | -23.22M 2.90% | -70.72M 204.60% | -117.80M 66.58% | -178.55M 51.56% | -293.19M 64.21% | -342.30M 16.75% | |
capital expenditure | -1.01M - | -387K 61.83% | -1.10M 183.98% | -18.89M 1,619.02% | -10.50M 44.41% | -3.95M 62.35% | -3.81M 3.69% | |
free cash flow | -23.58M - | -23.60M 0.11% | -71.82M 204.27% | -136.69M 90.33% | -189.05M 38.30% | -297.14M 57.18% | -346.11M 16.48% |
All numbers in (except ratios and percentages)